Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule associated tyrosine carboxypeptidase 2 (MATCAP2) is a protein-coding enzyme predicted to exhibit carboxypeptidase and metallopeptidase activities, contributing to the processing and modification of tyrosine residues in proteins. It is likely involved in proteolytic cleavage, specifically at protein termini. MATCAP2 is encoded by the gene with identifiers such as HGNC: 22206 and NCBI Gene: 23366 (human); an ortholog exists in rodent genomes. MATCAP2 belongs to the metallocarboxypeptidase family and is implicated in post-translational protein processing but has no confirmed, direct links to specific diseases or clinical drugs based on the available data. The various aliases reflect its identification across different species and databases, but all refer to the same putative enzymatic function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule associated tyrosine carboxypeptidase 2 (MATCAP2).